Johnson & Johnson at Leerink Global Healthcare Conference Transcript
Okay. I guess we have to start. Okay. Hi. Good afternoon, everyone. Thanks for joining us.
My name is Danielle Antalffy. I'm one of the senior med tech analysts here at SVB Leerink. And we are very lucky for the second year in a row to have Ashley McEvoy from Johnson & Johnson. She's Head of the Devices Group.
Before we get started, we also have Matt Stuckley from Investor Relations, and he will read forward-looking statements.
Thanks, Danielle. Good afternoon, everyone.
Please be aware that some statements made today may be considered forward-looking or utilize non-GAAP measures. Please refer to our SEC filings, in particular our 10-K, which discuss the risks and uncertainties around forward-looking statements as well as our website at investor.jnj.com for reconciliations to comparable GAAP measures. Finally, any remarks regarding financial
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |